title: Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin.
authors.affiliation: Department of Hygiene and Public Health, Nippon Medical School, Japan. Electronic address: kawada@nms.ac.jp.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kawada
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D001562:Benzimidazoles; D000069604:Dabigatran; D006470:Hemorrhage; D006801:Humans; D009025:Morpholines; D011720:Pyrazoles; D000069552:Rivaroxaban; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran
keywords: Atrial fibrillation; Bleeding risk; Direct oral anticoagulants